Literature DB >> 24524234

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.

Dm Skowronski1, C Chambers, S Sabaiduc, G De Serres, Ja Dickinson, Al Winter, K Fonseca, Jb Gubbay, H Charest, M Petric, M Krajden, Sm Mahmud, P Van Caeseele, Tl Kwindt, A Eshaghi, N Bastien, Y Li.   

Abstract

The 2013/14 influenza season to date in Canada has been characterised by predominant (90%) A(H1N1)pdm09 activity. Vaccine effectiveness (VE) was assessed in January 2014 by Canada's sentinel surveillance network using a test-negative case-control design. Interim adjusted-VE against medically-attended laboratory-confirmed influenza A(H1N1)pdm09 infection was 74% (95% CI: 58-83). Relative to vaccine, A(H1N1)pdm09 viruses were antigenically similar and genetically well conserved, with most showing just three mutations across the 50 amino acids comprising antigenic sites of the haemagglutinin protein.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24524234     DOI： 10.2807/1560-7917.es2014.19.5.20690

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  19 in total

1.  Influenza Vaccine Effectiveness in a Low-Income, Urban Community Cohort.

Authors:  Marie Smithgall; Celibell Y Vargas; Carrie Reed; Lyn Finelli; Philip LaRussa; Elaine L Larson; Lisa Saiman; Melissa S Stockwell
Journal:  Clin Infect Dis       Date:  2015-09-28       Impact factor: 9.079

2.  Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons.

Authors:  Michael L Jackson; Lisa A Jackson; Burney Kieke; David McClure; Manjusha Gaglani; Kempapura Murthy; Ryan Malosh; Arnold Monto; Richard K Zimmerman; Ivo M Foppa; Brendan Flannery; Mark G Thompson
Journal:  Vaccine       Date:  2015-08-11       Impact factor: 3.641

3.  Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.

Authors:  Sophia Ng; Saira Saborio; Guillermina Kuan; Lionel Gresh; Nery Sanchez; Sergio Ojeda; Eva Harris; Angel Balmaseda; Aubree Gordon
Journal:  Vaccine       Date:  2017-10-03       Impact factor: 3.641

4.  Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015.

Authors:  Rodica Gilca; Danuta M Skowronski; Monique Douville-Fradet; Rachid Amini; Nicole Boulianne; Isabelle Rouleau; Christine Martineau; Hugues Charest; Gaston De Serres
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

5.  Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.

Authors:  Masayoshi Shinjoh; Norio Sugaya; Yoshio Yamaguchi; Yuka Tomidokoro; Shinichiro Sekiguchi; Keiko Mitamura; Motoko Fujino; Hiroyuki Shiro; Osamu Komiyama; Nobuhiko Taguchi; Yuji Nakata; Naoko Yoshida; Atsushi Narabayashi; Michiko Myokai; Masanori Sato; Munehiro Furuichi; Hiroaki Baba; Hisayo Fujita; Akihiro Sato; Ichiro Ookawara; Kenichiro Tsunematsu; Makoto Yoshida; Mio Kono; Fumie Tanaka; Chiharu Kawakami; Takahisa Kimiya; Takao Takahashi; Satoshi Iwata
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014.

Authors:  Johanna M McAnerney; Florette Treurnicht; Sibongile Walaza; Adam L Cohen; Stefano Tempia; Senzo Mtshali; Amelia Buys; Lucille Blumberg; Cheryl Cohen
Journal:  Influenza Other Respir Viruses       Date:  2015-07       Impact factor: 4.380

7.  Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.

Authors:  S G Sullivan; K S Carville; M Chilver; J E Fielding; K A Grant; H Kelly; A Levy; N P Stocks; S S Tempone; A K Regan
Journal:  Epidemiol Infect       Date:  2016-04-29       Impact factor: 4.434

8.  Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.

Authors:  Brendan Flannery; Swathi N Thaker; Jessie Clippard; Arnold S Monto; Suzanne E Ohmit; Richard K Zimmerman; Mary Patricia Nowalk; Manjusha Gaglani; Michael L Jackson; Lisa A Jackson; Edward A Belongia; Huong Q McLean; LaShondra Berman; Angie Foust; Wendy Sessions; Sarah Spencer; Alicia M Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-02-21       Impact factor: 17.586

9.  Seasonal Influenza Vaccination amongst Medical Students: A Social Network Analysis Based on a Cross-Sectional Study.

Authors:  Rhiannon Edge; Joseph Heath; Barry Rowlingson; Thomas J Keegan; Rachel Isba
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

10.  Influenza A H1N1 pandemic strain evolution--divergence and the potential for antigenic drift variants.

Authors:  Eili Y Klein; Adrian W R Serohijos; Jeong-Mo Choi; Eugene I Shakhnovich; Andrew Pekosz
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.